FDA Drug Application (202517) for TELMISARTAN AND AMLODIPINE by TORRENT PHARMS LTD

Back to FDA Applications sponsored by TORRENT PHARMS LTD

Application Number202517
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE;40MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTELMISARTAN AND AMLODIPINE
Active IngredientAMLODIPINE BESYLATE; TELMISARTAN

Active IngredientCount
List of drugs with Active Ingredient AMLODIPINE BESYLATE21
List of drugs with Active Ingredient TELMISARTAN7


Back to FDA Applications sponsored by TORRENT PHARMS LTD